Routine NHS access to spinal muscular atrophy treatments offers new hope for patients and families
Posted:
SMA is a rare, inherited condition that causes progressive muscle weakness, affecting movement, breathing and swallowing. People living with spinal muscular atrophy (SMA) in England are set to gain routine access to two potentially life-changing treatments, following our publication of final draft guidance today.
The number of doctors and experts that bridge the gap between university research and the NHS – translating discoveries into patient care – is "ageing and shrinking", the Academy of Medical Sciences has warned.
The UK's life sciences industry generated £146.9bn in…
A new machine learning tool developed by researchers at the Queensland Institute of Medical Research Berghofer can help pathologists identify subtle cancer biomarkers in standard tissue samples.
The tool, called STimage, applies spatial analysis to hematoxylin and eosin-stained (H&E) tissue…
Attendees
Sponsors and Exhibitors
Contact us